Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles

The identification of peptide vaccine candidates to date has been focused on human leukocyte antigen (HLA)-A2 and -A24 alleles. In this study, we attempted to identify cytotoxic T lymphocyte (CTL)-directed Lck-derived peptides applicable to HLA-A11(+), -A31(+), or -A33(+) cancer patients, because th...

Descripción completa

Detalles Bibliográficos
Autores principales: Naito, M, Komohara, Y, Ishihara, Y, Noguchi, M, Yamashita, Y, Shirakusa, T, Yamada, A, Itoh, K, Harada, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360277/
https://www.ncbi.nlm.nih.gov/pubmed/18043580
http://dx.doi.org/10.1038/sj.bjc.6604071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360277/
https://www.ncbi.nlm.nih.gov/pubmed/18043580
http://dx.doi.org/10.1038/sj.bjc.6604071

Ejemplares similares